FederalDue Nov 10, 2026
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for emerging and chronic infections. The CTEUs design and implement clinical trials and studies, while the NCC provides the administrative and operational framework for a collaborative, integrated network and engages with experts in the field to solicit and generate clinical trial concepts. The NCC and CTEUs will collaboratively create opportunities to advance investigators early in their careers and those new to the field.
Amount not specifiedOfficial notice ↗ FederalDue Nov 10, 2026
National Institutes of Health
The purpose of this notice of funding opportunity (NOFO) is to support a Clinical Research Network (CRN) on Antimicrobial Resistance (AMR). The program aims to design, implement, and manage clinical research that addresses pivotal clinical questions related to AMR through a coordinated and integrated CRN. The CRN will comprise four centers: the Scientific Leadership Center (SLC), the Clinical Operations Center (COC), the Laboratory Center (LC), and the Statistics and Data Coordination Center (SDCC).
Amount not specifiedOfficial notice ↗ FederalDue Nov 10, 2026
National Institutes of Health
This Notice of Funding Opportunity (NOFO) invites applications proposing a Data Coordinating Center that integrates and disseminates multiscale mouse brain datasets for the aging and Alzheimer's disease (AD) research community. The Data Coordinating Center will establish the Aging and AD Mouse Brain Atlas (AD-MBA), which will serve as a central, unified research resource for multi-omic and connectomic mouse brain datasets emerging from the NIA AD Multimodal Atlas Projects (AD-MAPs). The Data Coordinating Center will (1) leverage the NIA-supported AD Knowledge Portal data infrastructure to facilitate hosting, deposition, and dissemination of multimodal datasets generated by the AD-MAPs program, (2) facilitate collaborative analyses among the data-contributing teams, (3) develop/optimize and incorporate tools for multiscale integration of multi-omics and connectomics datasets, and (4) create a broadly accessible web-based interface for the visualization and dissemination of integrated multiscale data.
Amount not specifiedOfficial notice ↗ FederalDue Nov 10, 2026
National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens for basic, clinical, or epidemiological cancer research. The NOFO solicits R61 applications for early-stage projects proposing proof-of-concept/pilot studies to test the technical feasibility of the proposed method, tool, assay, platform, or instrument. Technologies proposed for development may have potential for widespread applicability but must be focused for this program on cancer-relevant use cases. Projects proposing to apply or use existing technologies for hypothesis-driven research where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
FederalDue Nov 10, 2026
National Institutes of Health
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens used for basic, clinical, or epidemiological cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been overcome, as demonstrated with supportive preliminary data, but still require further development and rigorous technical validation to encourage adoption by the research community. Well-suited applications must propose the development of technologies that offer the potential to accelerate and/or enhance research in the areas of cancer biology, early detection and screening, clinical diagnosis, treatment, cancer control, epidemiology. Technologies proposed for development may have potential for widespread applicability but must be focused in this proposal on cancer-relevant use cases. Projects proposing to apply or use existing technologies for hypothesis-driven research where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
FederalDue Nov 10, 2026
National Institutes of Health
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb). These applications will target intermediate size populations of patients living with amyotrophic lateral sclerosis (ALS) who are not eligible for ongoing clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of ALS.
Amount not specifiedOfficial notice ↗ FederalDue Nov 10, 2026
National Institute of Food and Agriculture
The NLGCA Program, under assistance listing number 10.326, will assist NLGCA institutions in maintaining and expanding their capacity to conduct education, research, outreach, and integrated activities relating to agriculture, renewable resources, and other similar disciplines. NLGCA institutions may use the funds to maintain and expand capacity:
1. to successfully compete for funds from Federal grants and other sources to carry out educational, research, outreach, and integrated activities that address priority concerns of national, regional, State, and local interest;
2. to disseminate information relating to priority concerns to:
a. interested members of the agriculture, renewable resources, and other relevant communities;
b. the public; and
c. any other interested entity;
3. to encourage members of the agriculture, renewable resources, and other relevant communities to participate in priority education, research, outreach, and integrated activities by providing matching funds to leverage grant resources, and through:
a. the purchase or other acquisition of equipment and other infrastructure (not including alteration, repair, renovation, or construction of buildings);
b. the professional growth and development of the faculty of the NLGCA Institution; and
c. the development of graduate assistantships.
$30,000 – $750,000Official notice ↗ FederalDue Nov 12, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of spinal cord injury (SCI).
Distinctive Features: This funding opportunity contains an Early-Career Partnership Option, which allows for two Principal Investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the Initiating PI will submit a pre-application, but all PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate award to the recipient organization(s). Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
Applications to this funding opportunity must name at least two spinal cord injury (SCI) community partners (e.g., SCI Lived-Experience Consultants, representatives of community-based organizations) who will provide advice and consultation throughout the planning and implementation of the research project.
Amount not specifiedOfficial notice ↗ FederalDue Nov 12, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Translational Research Award (TRA) supports translational research that will accelerate the movement of promising ideas in spinal cord injury (SCI) research into clinical applications.
Distinctive Features:
• This funding opportunity contains an Early-Career Partnership Option, which allows for two principal investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate award to the recipient organization(s). Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
• Applications to this funding opportunity must name at least one SCI community partner (e.g., SCI Lived-Experience Consultant, representative of community-based organizations) who will provide advice and consultation throughout the planning and implementation of the research project.
Amount not specifiedOfficial notice ↗ FederalDue Nov 12, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Translation Research Award (CTRA) supports high-impact, new, or emerging clinical research that requires additional preliminary studies, such as feasibility, pilot, or optimization, to prepare for future larger-scale clinical trials or implementation. Primary objectives of this mechanism include:
• Accelerating the translation of current and emerging techniques or interventions into clinical use by addressing specific barrier(s) to clinical success for the purpose of de-risking or informing the design of definitive trials.
• Identifying the most effective diagnosis, treatment and rehabilitation options to support critical decision-making for patients, clinicians, care partners and policymakers.
Distinctive Features:
• This funding opportunity contains an Early-Career Partnership Option, which allows for two principal investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
• Applications to this funding opportunity must name at least two spinal cord injury (SCI) community partners who will provide advice and consultation throughout the planning and implementation of the research project.
Amount not specifiedOfficial notice ↗ FederalDue Nov 12, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas.
Distinctive Features:
· For interventions that require Investigational New Drug (IND)/Investigational Device Exemption (IDE) or equivalent regulatory authorizations for clinical testing, the IND/IDE application or equivalent must be submitted to the relevant Regulatory Agency by the CTA application submission deadline. In addition, applicants must provide documentation of communication from the Regulatory Agency indicating that the IND/IDE or equivalent is active/safe to proceed by March 1, 2027, in order for the CTA application to be considered for funding. Refer to Attachment 7: Regulatory Strategy for further details.
· Scored peer review criteria include Clinical Impact; Research Strategy and Feasibility; Recruitment, Accrual, Retention; Regulatory Strategy and Transition Plan; Statistical Plan and Data Analysis; Ethical Considerations; Personnel and Communication.
· Programmatic review criteria include adherence to the intent of the CTA, contribution to program portfolio, relative impact and relevance to military health.
https://cdmrp.health.mil/pubs/press/2026/vrppreann
Amount not specifiedOfficial notice ↗ FederalDue Nov 12, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials during or by the end of the period of performance. The TRA may be used to support preclinical studies, clinical research or a pilot clinical trial, but not a full-scale clinical trial. Research must align with at least one of the FY26 VRP Focus Areas.
Distinctive Features:
· If developing new drugs or device(s), the research team must include expertise in the regulatory approval process.
· The TRA includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI.
· Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, Personnel and Post-Award Transition Plan.
· Programmatic review criteria include adherence to the intent of the TRA, contribution to the VRP portfolio, relative impact and relevance to military health.
· The VRP may share FY26 TRA applications and reviews with the National Eye Institute (NEI) for independent funding consideration.
https://cdmrp.health.mil/pubs/press/2026/vrppreann
Amount not specifiedOfficial notice ↗ FederalDue Nov 12, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Investigator-Initiated Research Award (IIRA) supports studies that have the potential to make an important contribution to spinal cord injury (SCI) research, patient care and/or quality of life. May focus on any phase of research from basic through translational science, though studies that focus solely on identifying intervention targets are discouraged.
Distinctive Features:
• This funding opportunity contains an Early-Career Partnership Option, which allows for two Principal Investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the initiating PI will submit a pre-application, but all PIs will need to submit full applications. The partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate award to the recipient organization(s). Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.
Amount not specifiedOfficial notice ↗ FederalDue Nov 12, 2026
Defense Health Agency Contracting Activity - DHACA
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Investigator-Initiated Research Award (IIRA) supports basic through early translational research that will yield highly impactful discoveries or major advancements in the research and/or patient care of eye injury and/or visual dysfunction related to military exposure. The IIRA may be used to support preclinical studies and/or clinical research. Research must align with at least one of the FY26 VRP Focus Areas. The IIRA cannot be used to support clinical trials.
Distinctive Features:
· The IIRA offers two Funding Levels to support research at different stages and the exploration/development of ideas of different maturity levels.
· Funding Level 2 includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI.
· Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, and Personnel.
· Programmatic review criteria include adherence to the intent of the IIRA, contribution to the VRP portfolio, relative impact, and relevance to military health.
· The VRP may share FY26 IIRA applications and reviews with the National Eye Institute (NEI) for independent funding consideration.
https://cdmrp.health.mil/pubs/press/2026/vrppreann
Amount not specifiedOfficial notice ↗ FederalDue Nov 13, 2026
Institute of Museum and Library Services
The Native American/Native Hawaiian Museum Services program (NANH) supports Native American Tribes, Alaska Native Villages, and organizations that primarily serve and represent Native Hawaiians in sustaining heritage, culture, and knowledge. The program supports projects such as educational services and programs, workforce professional development, organizational capacity building, community engagement, and collections stewardship.
$5,000 – $250,000Official notice ↗ FederalDue Nov 13, 2026
Institute of Museum and Library Services
The Native American Library Services Enhancement Grants program (NAE) assists eligible Native Communities in sustaining and improving library services with their communities. As information needs change, Tribal libraries must be able to serve as knowledge and resource centers to benefit their users and the wellness of their communities. The program supports Native Communities across the country to address their individual information needs and priorities.
$50,000 – $150,000Official notice ↗ FederalDue Nov 13, 2026
Institute of Museum and Library Services
The Native Hawaiian Library Services (NH) program is designed to assist Native Hawaiian serving organizations in sustaining and improving library services with their communities. As information needs change, Native Hawaiian organizations must be able to serve as knowledge and resource centers to benefit their users and the wellness of their communities. The program supports organizations across the islands and country to address their individual information needs and priorities.
$50,000 – $150,000Official notice ↗ FederalDue Nov 13, 2026
Institute of Museum and Library Services
The Native American Basic Grants (NAB) program assists eligible Native Communities in establishing, sustaining, and improving library services and operations with their communities. As information needs change, Tribal libraries must be able to serve as knowledge and resource centers to benefit their users and the wellness of their communities. The NAB program supports Native Communities across the country to address their individual information needs and priorities.
FederalDue Nov 13, 2026
Institute of Museum and Library Services
Laura Bush 21st Century Librarian (LB21) projects build a library and archival workforce that can meet the information needs of communities of all types and sizes and increase the institutional capacity of libraries, archives, and library and information science graduate programs across the country.
$75,000 – $1,000,000Official notice ↗ FederalDue Nov 13, 2026
Institute of Museum and Library Services
National Leadership Grants for Libraries (NLG-L) projects enhance the quality of library services nationwide. The program supports projects that: promote adult reading, and health and financial literacies; focus on programming and archival practices related to our shared American history; manage and preserve the national information infrastructure; serve the public’s information and education needs; enhance library and information services through effective and efficient use of new and emerging technologies; improve community prosperity; provide emergency services to communities during disasters and emergencies; and build collaborative partnerships between libraries, archives, and museums that benefit the communities they serve.
$25,000 – $1,000,000Official notice ↗ FederalDue Nov 13, 2026
Institute of Museum and Library Services
The National Leadership Grants for Museums program (NLG-M) invests in projects that address critical needs of the museum field. NLG-M projects have the potential to advance practice in the profession to strengthen museum services for the public through the development and replication of model practices, tools, research findings, and collaborations, including through the creative and effective use of new and emerging technologies.
$50,000 – $750,000Official notice ↗ FederalDue Nov 13, 2026
Institute of Museum and Library Services
Museums Empowered: Professional Development Opportunities for Museum Staff is a special initiative of the Museums for America grant program, designed to support projects that use learning and training to generate change and growth within museums of all types and sizes.
$5,000 – $350,000Official notice ↗ FederalDue Nov 13, 2026
Institute of Museum and Library Services
The Museum Grants for American Latino History and Culture (ALHC) program supports projects that build the capacity of American Latino history and culture museums to serve their communities and advance the growth and development of a professional workforce in American Latino cultural institutions.
$5,000 – $500,000Official notice ↗ FederalDue Nov 13, 2026
Institute of Museum and Library Services
The 21st Century Museum Professionals (21MP) grant program supports projects that build career pathways, strengthen professional networks, and identify and share effective workforce education and training practices in the museum field.
$100,000 – $500,000Official notice ↗